LU90341I2 - 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette) - Google Patents

75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)

Info

Publication number: LU90341I2
Authority: LU; Luxembourg
Prior art keywords: desogestrel; cerazette; absence; ketodesogestrel; regimen
Prior art date: 1990-12-17

Application number

LU90341C

Other languages

English (en)

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-17

Filing date

1999-01-27

Publication date

1999-03-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90341(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-01-27 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1999-03-29 Publication of LU90341I2 publication Critical patent/LU90341I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

LU90341C 1990-12-17 1999-01-27 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette) LU90341I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP90203371		1990-12-17

Publications (1)

Publication Number	Publication Date
LU90341I2 true LU90341I2 (fr)	1999-03-29

Family

ID=8205203

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU90341C LU90341I2 (fr)	1990-12-17	1999-01-27	75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)

Country Status (20)

Country	Link
US (1)	US5461041A (fr)
EP (1)	EP0491443B1 (fr)
JP (1)	JPH04290829A (fr)
KR (1)	KR100221008B1 (fr)
CN (1)	CN1036834C (fr)
AT (1)	ATE135218T1 (fr)
AU (1)	AU649082B2 (fr)
CA (1)	CA2057714C (fr)
DE (2)	DE19975011I2 (fr)
DK (1)	DK0491443T3 (fr)
ES (1)	ES2087237T3 (fr)
FI (1)	FI98984C (fr)
GR (1)	GR3020180T3 (fr)
IE (1)	IE71202B1 (fr)
LU (1)	LU90341I2 (fr)
NL (1)	NL990003I2 (fr)
NO (2)	NO2002013I2 (fr)
NZ (1)	NZ240969A (fr)
PT (1)	PT99818B (fr)
ZA (1)	ZA919732B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4133680A1 (de) *	1991-10-11	1993-04-15	Metallgesellschaft Ag	Stabilisierte staerke, verwendung der stabilisierten staerke und verfahren zu ihrer herstellung
DE4227989A1 (de) *	1992-08-21	1994-06-09	Schering Ag	Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5395627A (en) *	1992-09-04	1995-03-07	Akzo N.V.	Pharmaceutical granulate
US6407082B1 (en) *	1996-09-13	2002-06-18	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a vitamin D compound
ZA949929B (en) *	1993-12-23	1995-08-23	Akzo Nobel Nv	Sugar-coated pharmaceutical dosage unit.
DE4405590C1 (de) *	1994-02-22	1995-07-20	Hesch Rolf Dieter Prof Dr Med	Mittel zur postmenopausalen Hormonbehandlung
KR100384264B1 (ko) *	1994-09-22	2003-08-30	악조 노벨 엔.브이.	습식과립화에의한 투여단위의제조방법
US6511970B1 (en)	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en)	2000-03-21	2004-07-20	Gustavo Rodriguez	Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en)	1996-09-13	2000-03-07	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en)	1996-09-13	2000-02-22	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of progestin products
AU4134599A (en) *	1998-04-07	1999-10-25	Akzo Nobel N.V.	Progestogen-only contraceptive kit
WO2000009136A1 (fr) *	1998-08-11	2000-02-24	Akzo Nobel N.V.	Kit contraceptif base uniquement sur le progestogene et permettant un controle efficace du cycle
US20040176336A1 (en) *	2000-03-21	2004-09-09	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) *	2000-03-21	2005-05-26	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0114746D0 (en)	2001-06-16	2001-08-08	Boots Co Plc	Medicinal composition
US6574033B1 (en)	2002-02-27	2003-06-03	Iridigm Display Corporation	Microelectromechanical systems device and method for fabricating same
TW200403075A (en) *	2002-05-29	2004-03-01	Akzo Nobel Nv	Progestagenic dosage units
DE602004016311D1 (de) *	2003-04-29	2008-10-16	Organon Nv	Verfahren zur verfestigung, bei welchem ein anti-lösungsmittel benutzt wird
DE102005053771A1 (de) *	2005-11-09	2007-05-10	Grünenthal GmbH	Darreichform zur hormonalen Kontrazeption
DE202010010589U1 (de)	2010-07-22	2010-10-14	Bayer Schering Pharma Aktiengesellschaft	Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption
EP2730284A1 (fr) *	2012-11-12	2014-05-14	Naari AG	Composition uniquement à base de levonorgestrel pour contraception orale optimisée avec contenu de lévonorgestrel défini, posologie et préparation pharmaceutique
WO2017000081A1 (fr) *	2015-06-30	2017-01-05	上海交通大学	Utilisation de l'étonorgestrel dans la préparation d'un produit permettant de lutter contre l'adénocarcinome de la prostate
US11679114B2 (en)	2021-07-26	2023-06-20	Navad Life Sciences Pte	Progestogen-only oral contraception

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4066757A (en) *	1973-03-26	1978-01-03	Ortho Pharmaceutical Corporation	Oral contraceptive regimen
ES2054784T3 (es) *	1987-08-08	1994-08-16	Akzo Nv	Un metodo para la fabricacion de un implante.

1991
- 1991-12-09 IE IE427191A patent/IE71202B1/en not_active IP Right Cessation
- 1991-12-10 ZA ZA919732A patent/ZA919732B/xx unknown
- 1991-12-12 AT AT91203328T patent/ATE135218T1/de not_active IP Right Cessation
- 1991-12-12 EP EP91203328A patent/EP0491443B1/fr not_active Expired - Lifetime
- 1991-12-12 ES ES91203328T patent/ES2087237T3/es not_active Expired - Lifetime
- 1991-12-12 DK DK91203328.9T patent/DK0491443T3/da active
- 1991-12-12 DE DE1999175011 patent/DE19975011I2/de active Active
- 1991-12-12 DE DE69117902T patent/DE69117902T2/de not_active Expired - Lifetime
- 1991-12-13 NZ NZ240969A patent/NZ240969A/en not_active IP Right Cessation
- 1991-12-13 AU AU89678/91A patent/AU649082B2/en not_active Expired
- 1991-12-16 NO NO2002013C patent/NO2002013I2/no unknown
- 1991-12-16 KR KR1019910023066A patent/KR100221008B1/ko not_active Expired - Lifetime
- 1991-12-16 PT PT99818A patent/PT99818B/pt not_active IP Right Cessation
- 1991-12-16 FI FI915913A patent/FI98984C/fi active
- 1991-12-16 NO NO914970A patent/NO178686C/no not_active IP Right Cessation
- 1991-12-16 CA CA002057714A patent/CA2057714C/fr not_active Expired - Lifetime
- 1991-12-17 JP JP3333717A patent/JPH04290829A/ja active Pending
- 1991-12-17 CN CN91107997A patent/CN1036834C/zh not_active Expired - Lifetime
1994
- 1994-01-19 US US08/183,644 patent/US5461041A/en not_active Expired - Lifetime
1996
- 1996-06-07 GR GR960401542T patent/GR3020180T3/el unknown
1999
- 1999-01-22 NL NL990003C patent/NL990003I2/nl unknown
- 1999-01-27 LU LU90341C patent/LU90341I2/fr unknown

Also Published As

Publication number	Publication date
CA2057714C (fr)	2002-10-01
NO914970D0 (no)	1991-12-16
KR920011514A (ko)	1992-07-24
KR100221008B1 (ko)	1999-09-15
DK0491443T3 (da)	1996-06-24
PT99818B (pt)	1999-05-31
NO2002013I2 (no)	2007-02-26
DE69117902T2 (de)	1996-08-29
CA2057714A1 (fr)	1992-06-18
DE19975011I2 (de)	2005-05-04
FI98984B (fi)	1997-06-13
AU649082B2 (en)	1994-05-12
US5461041A (en)	1995-10-24
ZA919732B (en)	1992-09-30
AU8967891A (en)	1992-06-18
ATE135218T1 (de)	1996-03-15
IE71202B1 (en)	1997-02-12
FI915913A0 (fi)	1991-12-16
NZ240969A (en)	1994-04-27
FI915913L (fi)	1992-06-18
DE69117902D1 (de)	1996-04-18
IE914271A1 (en)	1992-06-17
GR3020180T3 (en)	1996-09-30
NO178686B (no)	1996-02-05
JPH04290829A (ja)	1992-10-15
FI98984C (fi)	1997-09-25
EP0491443A1 (fr)	1992-06-24
CN1036834C (zh)	1997-12-31
NO178686C (no)	1996-05-15
NL990003I1 (nl)	1999-04-01
NL990003I2 (nl)	1999-05-03
EP0491443B1 (fr)	1996-03-13
NO914970L (no)	1992-06-18
CN1062465A (zh)	1992-07-08
ES2087237T3 (es)	1996-07-16
PT99818A (pt)	1992-11-30

Publication	Publication Date	Title
LU90341I2 (fr)	1999-03-29	75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
LU90634I2 (fr)	2000-12-15	Gestodene et ethinylestradiol/minesse
NZ234051A (en)	1991-09-25	Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
KR960704553A (ko)	1996-10-09	적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen)
IL122109A0 (en)	1998-04-05	A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same
BG104451A (en)	2000-12-29	Antiestrogen and progestin-containing peroral contraceptives
MX9804395A (es)	1998-09-30	Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno.
NZ333750A (en)	2000-09-29	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
RU94040720A (ru)	1997-05-27	Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств
MX9707009A (es)	1997-11-29	Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.